Valuation
- Market cap
- 1,122,000
- Revenue TTM
- $0
- Net income TTM
- $1,370,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,100
- Avg volume
- 13,964
- Day's range
- $0.65 – $0.65
- Shares out
- 1,810,000
- Stochastic %K
- 26%
- Beta
- 1.94
- Analysts
- —
- Price target
- $4.00
Company profile
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 212 994 8200
- Website
- https://www.protagenic.com
- Address
- 149 Fifth Avenue, New York, United States
Latest news
No headlines yet.
